Pfizer, BioNTech Covid-19 vaccines granted FDA fast track status

167 Aufrufe

Danke für die Bewertung! Teile es mit Deinen Freunden!

Danke für Deine Bewertung!

Published Jul 15, 2020

Pfizer and BioNTech SE were granted fast track designation by the FDE for two of the companies’ four vaccine candidates against the coronavirus. Pfizer shares added 2%. BioNTech added 5%. CNBC's Joe Kernen breaks down the news and what it means for the market. Subscribe to CNBC PRO for access to investor and analyst insights and more: https://cnb.cx/3dIH56N

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC

#CNBC
#CNBCTV

Kategorien: Gesundheits Tipps

Kommentare deaktiviert.

Anmelden

Pfizer, BioNTech Covid-19 vaccines granted FDA fast track status

Als nächstes